# Supernus Pharmaceuticals, Inc.: Form 8-K, filed Feb 12, 2026

- Company: [Supernus Pharmaceuticals, Inc.](/companies/supn.md) (CIK 1356576)
- Form: 8-K
- Filed: 2026-02-12
- Accepted by EDGAR: Feb 12, 2026, 16:16 ET
- Period: 2026-02-12
- Accession: 0001356576-26-000002
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1356576/000135657626000002/supn-20260212.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1356576/000135657626000002/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1356576/000135657626000002/supn-20260212.htm

Filed Feb 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001356576-26-000002. Last ingested by Listed: Nov 2, 2026, 17:48 ET. No prices; not investment advice.